HealthQuill partial face transplant
Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises in heart diseases, for up to 1.03 billion euros ($1.1 billion).
Drugs Health Medical

World’s first whole-eye and partial face transplant recipient is doing well

HQ Team September 10, 2024: Aaron James, 46, the first-ever person to undergo a combined whole-eye and partial face transplant, is doing well.

Read More
X